Diabetes, Vol 40, Issue 7 908-919, Copyright © 1991 by American Diabetes Association

ARTICLES

Transplantation of purified islet cells in diabetic rats. I. Standardization of islet cell grafts

DG Pipeleers, M Pipeleers-Marichal, JC Hannaert, M Berghmans, PA In't Veld, J Rozing, M Van de Winkel and W Gepts
Department of Metabolism and Endocrinology, Vrije Universeit Brussel, Belgium.

A standardized procedure was developed for the preparation of rat islet cell grafts with selected cell number and composition. After collagenase digestion of pancreases and elutriation of tissue fragments, islets were isolated and dissociated, and cells were purified by autofluorescence-activated cell sorting. Approximately 30% of the initial beta-cell mass was lost during digestion and elimination of small mostly exocrine particles. Fifty percent was recovered in isolated islet preparations and 30% in the purified beta-cell suspensions of greater than 95% purity and viability. Sorting according to cellular flavin adenine dinucleotide content discriminated islet beta-cells from islet endocrine non-beta-cells, fibroblasts, leukocytes, and exocrine cells. Purified endocrine islet cell grafts were prepared by aggregating 10(6) pure beta-cells with or without 8 x 10(5) pure endocrine non-beta-cells. In contrast to intact islets, the purified aggregates were devoid of nonendocrine and damaged cells. Intraportal implantation of a pure beta-cell graft rapidly and permanently normalized the diabetic state of streptozocin-administered animals. The standardized preparation of purified beta-cell grafts allows us to address several metabolic and immunological questions concerning islet cell transplantation in diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Keymeulen, P. Gillard, C. Mathieu, B. Movahedi, G. Maleux, G. Delvaux, D. Ysebaert, B. Roep, E. Vandemeulebroucke, M. Marichal, et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft PNAS, November 14, 2006; 103(46): 17444 - 17449. [Abstract] [Full Text] [PDF]

				M. Bogdani, K. Suenens, T. Bock, M. Pipeleers-Marichal, P. In't Veld, and D. Pipeleers Growth and Functional Maturation of {beta}-Cells in Implants of Endocrine Cells Purified From Prenatal Porcine Pancreas Diabetes, December 1, 2005; 54(12): 3387 - 3394. [Abstract] [Full Text] [PDF]

				R. Bottino, A.N. Balamurugan, S. Bertera, M. Pietropaolo, M. Trucco, and J. D. Piganelli Preservation of Human Islet Cell Functional Mass by Anti-Oxidative Action of a Novel SOD Mimic Compound Diabetes, August 1, 2002; 51(8): 2561 - 2567. [Abstract] [Full Text] [PDF]

				J. Tu, B. E. Tuch, and Z. Si Expression and Regulation of Glucokinase in Rat Islet {beta}- and {alpha}-Cells during Development Endocrinology, August 1, 1999; 140(8): 3762 - 3766. [Abstract] [Full Text]